
ALL
Allstate Corporation (The)
Latest News for ALL
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allogene Therapeutics (ALLO – Research Report), Neur......
Citi analyst Adrian Lemme maintained a Buy rating on Aristocrat Leisure today and set a price target of A$71.00. According to TipRanks, Lemme is a ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Allogene Therapeutics (ALLO – Research Report), Ha......
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Allogene Therapeutics yesterday and set a price target of $7.00. Biegler covers the ......
Cantor Fitzgerald analyst Ryan Tunis maintained a Hold rating on Allstate yesterday and set a price target of $202.00. Tunis covers the Financial s......
Analysts have been eager to weigh in on the Financial sector with new ratings on Ally Financial (ALLY – Research Report) and OneMain Holdings (OMF ......
Morgan Stanley analyst Melinda Baxter maintained a Buy rating on Aristocrat Leisure today and set a price target of A$73.70. The company’s shares c......
Barclays analyst Julian Mitchell maintained a Hold rating on Allegion today and set a price target of $187.00. The company’s shares closed yesterda......
Mizuho Securities analyst Brett Linzey maintained a Hold rating on Allegion yesterday and set a price target of $170.00. The company’s shares close......
Morgan Stanley analyst Bob Huang maintained a Buy rating on Allstate today and set a price target of $245.00. The company’s shares closed yesterday......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 26 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALL | $202.29 | +2.2% | 1.36M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allstate Corporation (The) Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW